154 related articles for article (PubMed ID: 30608929)
1. Machine learning models to predict disease progression among veterans with hepatitis C virus.
Konerman MA; Beste LA; Van T; Liu B; Zhang X; Zhu J; Saini SD; Su GL; Nallamothu BK; Ioannou GN; Waljee AK
PLoS One; 2019; 14(1):e0208141. PubMed ID: 30608929
[TBL] [Abstract][Full Text] [Related]
2. Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C.
Konerman MA; Lu D; Zhang Y; Thomson M; Zhu J; Verma A; Liu B; Talaat N; Balis U; Higgins PDR; Lok ASF; Waljee AK
PLoS One; 2017; 12(11):e0187344. PubMed ID: 29108017
[TBL] [Abstract][Full Text] [Related]
3. Adapted time-varying covariates Cox model for predicting future cirrhosis development performs well in a large hepatitis C cohort.
Beste LA; Zhang X; Su GL; Van T; Ioannou GN; Oselio B; Tincopa M; Liu B; Singal AG; Zhu J; Waljee AK
BMC Med Inform Decis Mak; 2021 Dec; 21(1):347. PubMed ID: 34903225
[TBL] [Abstract][Full Text] [Related]
4. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
Ozel BD; Poyrazoğlu OK; Karaman A; Karaman H; Altinkaya E; Sevinç E; Zararsiz G
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations.
Tseng PL; Wang JH; Hung CH; Tung HD; Chen TM; Huang WS; Liu SL; Hu TH; Lee CM; Lu SN
Kaohsiung J Med Sci; 2013 Jul; 29(7):385-95. PubMed ID: 23768703
[TBL] [Abstract][Full Text] [Related]
8. Aspartate aminotransferase-to-platelet ratio index for fibrosis and cirrhosis prediction in chronic hepatitis C patients.
Silva RG; Fakhouri R; Nascimento TV; Santos IM; Barbosa LM
Braz J Infect Dis; 2008 Feb; 12(1):15-9. PubMed ID: 18553008
[TBL] [Abstract][Full Text] [Related]
9. Improvement of predictive models of risk of disease progression in chronic hepatitis C by incorporating longitudinal data.
Konerman MA; Zhang Y; Zhu J; Higgins PD; Lok AS; Waljee AK
Hepatology; 2015 Jun; 61(6):1832-41. PubMed ID: 25684666
[TBL] [Abstract][Full Text] [Related]
10. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
11. Dynamic prediction of risk of liver-related outcomes in chronic hepatitis C using routinely collected data.
Konerman MA; Brown M; Zheng Y; Lok AS
J Viral Hepat; 2016 Jun; 23(6):455-63. PubMed ID: 26893198
[TBL] [Abstract][Full Text] [Related]
12. A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy.
Yu ML; Lin SM; Lee CM; Dai CY; Chang WY; Chen SC; Lee LP; Lin ZY; Hsieh MY; Wang LY; Chuang WL; Liaw YF
Hepatology; 2006 Nov; 44(5):1086-97. PubMed ID: 17058238
[TBL] [Abstract][Full Text] [Related]
13. Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore.
Zhao Y; Thurairajah PH; Kumar R; Tan J; Teo EK; Hsiang JC
Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):143-148. PubMed ID: 30558838
[TBL] [Abstract][Full Text] [Related]
14. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis.
Loaeza-del-Castillo A; Paz-Pineda F; Oviedo-Cárdenas E; Sánchez-Avila F; Vargas-Vorácková F
Ann Hepatol; 2008; 7(4):350-7. PubMed ID: 19034235
[TBL] [Abstract][Full Text] [Related]
15. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C.
Silva Junior RG; Schmillevitch J; Nascimento Mde F; Miranda ML; Brant PE; Schulz PO; Vieira A; Szutan LA
Scand J Gastroenterol; 2014 Aug; 49(8):986-92. PubMed ID: 24742130
[TBL] [Abstract][Full Text] [Related]
16. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
[TBL] [Abstract][Full Text] [Related]
17. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
18. Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis.
Ioannou GN; Tang W; Beste LA; Tincopa MA; Su GL; Van T; Tapper EB; Singal AG; Zhu J; Waljee AK
JAMA Netw Open; 2020 Sep; 3(9):e2015626. PubMed ID: 32870314
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Machine Learning Approaches for Prediction of Advanced Liver Fibrosis in Chronic Hepatitis C Patients.
Hashem S; Esmat G; Elakel W; Habashy S; Raouf SA; Elhefnawi M; Eladawy M; ElHefnawi M
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):861-868. PubMed ID: 28391204
[TBL] [Abstract][Full Text] [Related]
20. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
